Home Healthcare Pharmaceuticals Urinary Tract Infection Market

Urinary Tract Infection Market Size, Share & Trends Analysis Report By Drug Class (Quinolones, β-lactam and Cephalosporins, Other), By Applications (Urethritis, Cystitis, Others), By Pathogen (Escherichia coli, Staphylococcus saprophyticus), By End-User (Hospitals, Clinics, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Urinary Tract Infection Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Quinolones
    2. β-lactam and Cephalosporins
    3. Other
  2. Urinary Tract Infection Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Urethritis
    2. Cystitis
    3. Others
  3. Urinary Tract Infection Market, By Pathogen 2022-2034 (USD MILLION/ Units)
    1. Escherichia coli
    2. Staphylococcus saprophyticus
  4. Urinary Tract Infection Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Clinics
    3. Others
  5. Urinary Tract Infection Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
  6. Regional Urinary Tract Infection Market
    1. North America
      1. North America Urinary Tract Infection Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
      2. North America Urinary Tract Infection Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Urethritis
        2. Cystitis
        3. Others
      3. North America Urinary Tract Infection Market By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Escherichia coli
        2. Staphylococcus saprophyticus
      4. North America Urinary Tract Infection Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. North America Urinary Tract Infection Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      6. U.S.
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      7. Canada
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
    2. Europe
      1. Europe Urinary Tract Infection Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
      2. Europe Urinary Tract Infection Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Urethritis
        2. Cystitis
        3. Others
      3. Europe Urinary Tract Infection Market By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Escherichia coli
        2. Staphylococcus saprophyticus
      4. Europe Urinary Tract Infection Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Europe Urinary Tract Infection Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      6. U.K.
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      7. Germany
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      8. France
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      9. Spain
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      10. Italy
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      11. Russia
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      12. Nordic
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      13. Benelux
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      14. Rest of Europe
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
    3. APAC
      1. APAC Urinary Tract Infection Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
      2. APAC Urinary Tract Infection Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Urethritis
        2. Cystitis
        3. Others
      3. APAC Urinary Tract Infection Market By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Escherichia coli
        2. Staphylococcus saprophyticus
      4. APAC Urinary Tract Infection Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. APAC Urinary Tract Infection Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      6. China
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      7. Korea
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      8. Japan
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      9. India
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      10. Australia
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      11. Taiwan
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      12. South East Asia
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      13. Rest of Asia-Pacific
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Urinary Tract Infection Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
      2. Middle East and Africa Urinary Tract Infection Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Urethritis
        2. Cystitis
        3. Others
      3. Middle East and Africa Urinary Tract Infection Market By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Escherichia coli
        2. Staphylococcus saprophyticus
      4. Middle East and Africa Urinary Tract Infection Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. Middle East and Africa Urinary Tract Infection Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      6. UAE
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      7. Turkey
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      8. Saudi Arabia
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      9. South Africa
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      10. Egypt
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      11. Nigeria
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      12. Rest of MEA
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
    5. LATAM
      1. LATAM Urinary Tract Infection Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
      2. LATAM Urinary Tract Infection Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Urethritis
        2. Cystitis
        3. Others
      3. LATAM Urinary Tract Infection Market By Pathogen 2022-2034 (USD MILLION/ Units)
        1. Escherichia coli
        2. Staphylococcus saprophyticus
      4. LATAM Urinary Tract Infection Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      5. LATAM Urinary Tract Infection Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      6. Brazil
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      7. Mexico
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      8. Argentina
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      9. Chile
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      10. Colombia
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
      11. Rest of LATAM
        1. Quinolones
        2. β-lactam and Cephalosporins
        3. Other
        4. Urethritis
        5. Cystitis
        6. Others
        7. Escherichia coli
        8. Staphylococcus saprophyticus
        9. Hospitals
        10. Clinics
        11. Others
        12. Hospital Pharmacies
        13. Retail Pharmacies
        14. Online Pharmacies
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.